Cyclosporine 0.05% Ophthalmic Emulsion

DRUG3 trials

Sponsors

Allergan, Surface Ophthalmics, Inc.

Conditions

Dry Eye DiseaseDry Eye Syndromes

Phase 2

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

CompletedNCT04734197

Surface Ophthalmics, Inc.Dry Eye Disease

Start: 2021-01-11End: 2022-03-25Updated: 2025-05-11

Phase 4

Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy

CompletedNCT02121847

AllerganDry Eye Syndromes

Start: 2014-04-03End: 2014-09-23Updated: 2019-04-18

Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®

CompletedNCT02554981

AllerganDry Eye Syndromes

Start: 2015-07-21End: 2016-03-24Updated: 2017-06-01